P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection
[...] there was no evidence of an association between HIV infection and increases in Ad5 titers in participants. [...] post-enrolment Ad5 infection is not a predisposing factor for HIV acquisition in the placebo group of the Step Trial.
Saved in:
Published in | Retrovirology Vol. 6; no. Suppl 3; p. P368 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
22.10.2009
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...] there was no evidence of an association between HIV infection and increases in Ad5 titers in participants. [...] post-enrolment Ad5 infection is not a predisposing factor for HIV acquisition in the placebo group of the Step Trial. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1742-4690 1742-4690 |
DOI: | 10.1186/1742-4690-6-S3-P368 |